4D Molecular Correlations

FDMT Stock

USD 7.87 0.37 4.93%

The current 90-days correlation between 4D Molecular Therapeutics and Bright Minds Biosciences is -0.01 (i.e., Good diversification). The correlation of 4D Molecular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

4D Molecular Correlation With Market

Good diversification

The correlation between 4D Molecular Therapeutics and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4D Molecular Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with FDMT Stock

0.71	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.83	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.71	INKT	Mink Therapeutics	Pair Corr
0.9	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.61	PEPG	PepGen	Pair Corr
0.82	RGNX	Regenxbio	Pair Corr
0.89	ADAP	Adaptimmune Therapeutics	Pair Corr
0.73	AFMD	Affimed NV	Pair Corr
0.77	STOK	Stoke Therapeutics	Pair Corr
0.95	BDTX	Black Diamond Therap	Pair Corr

Moving against FDMT Stock

0.82	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.67	NAMS	NewAmsterdam Pharma	Pair Corr
0.62	OPT	Opthea	Pair Corr
0.5	ESLAW	Estrella Immunopharma	Pair Corr
0.49	PHVS	Pharvaris BV	Pair Corr
0.47	PMVP	Pmv Pharmaceuticals	Pair Corr
0.37	PLRX	Pliant Therapeutics	Pair Corr
0.83	CRVS	Corvus Pharmaceuticals	Pair Corr
0.78	ABEO	Abeona Therapeutics	Pair Corr
0.75	AVTE	Aerovate Therapeutics	Pair Corr
0.64	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.58	VREX	Varex Imaging Corp	Pair Corr
0.35	AGIO	Agios Pharm	Pair Corr

Related Correlations Analysis

	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT
DRUG		0.63	0.56	0.64	-0.8	0.81	-0.55	0.72	0.01	DRUG
HPQ	0.63		0.81	0.81	-0.64	0.65	-0.66	0.75	0.03	HPQ
INTC	0.56	0.81		0.81	-0.69	0.62	-0.81	0.65	0.22	INTC
CVX	0.64	0.81	0.81		-0.84	0.7	-0.86	0.87	-0.08	CVX
KO	-0.8	-0.64	-0.69	-0.84		-0.74	0.88	-0.86	0.09	KO
TRV	0.81	0.65	0.62	0.7	-0.74		-0.56	0.75	0.18	TRV
JNJ	-0.55	-0.66	-0.81	-0.86	0.88	-0.56		-0.75	0.04	JNJ
JPM	0.72	0.75	0.65	0.87	-0.86	0.75	-0.75		-0.13	JPM
MSFT	0.01	0.03	0.22	-0.08	0.09	0.18	0.04	-0.13		MSFT
	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

JNJ	+ 0.88	KO
JPM	+ 0.87	CVX
TRV	+ 0.81	DRUG
INTC	+ 0.81	HPQ
CVX	+ 0.81	HPQ
CVX	+ 0.81	INTC

High negative correlations

JPM	- 0.86	KO
JNJ	- 0.86	CVX
KO	- 0.84	CVX
JNJ	- 0.81	INTC
KO	- 0.8	DRUG
JPM	- 0.75	JNJ

Risk-Adjusted Indicators

There is a big difference between FDMT Stock performing well and 4D Molecular Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 4D Molecular's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DRUG	49.12	28.18	2.88	(0.77)	4.62	(58.09)	9.23	(11.87)	1,471
HPQ	1.31	0.03	0.02	0.15	1.62	(1.30)	2.22	(2.63)	6.13
INTC	2.36	0.04	0.07	0.14	2.58	(2.68)	6.36	(3.50)	18.29
CVX	0.90	0.07	0.02	0.22	1.05	(0.93)	2.21	(1.79)	5.13
KO	0.68	(0.15)	0.00	(1.28)	0.00	0.00	1.11	(1.66)	4.00
TRV	1.08	0.15	0.11	0.27	1.17	(1.26)	1.93	(2.17)	11.31
JNJ	0.61	(0.10)	0.00	(0.37)	0.00	0.00	1.40	(1.42)	3.25
JPM	1.12	(0.01)	0.06	0.12	1.42	(1.19)	2.05	(2.00)	15.87
MSFT	0.90	(0.03)	(0.04)	0.07	1.49	(0.86)	2.09	(1.85)	8.19

4D Molecular Corporate Management

FAAAAI FAAP	Senior Pulmonology	Profile
Uneek Mehra	Chief Officer	Profile
JD Esq	Chief Officer	Profile
Mike Zanoni	VP Relations	Profile
Noriyuki MD	Chief Officer	Profile
Karen Carothers	Controller	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC